MaRS Centre, CR-3
101 College St,
Join us at an exceptional MaRS Future of Medicine speaker series event on December 12th, as Justin Canivet and Douglas Loe discuss life sciences companies on the public markets. They will provide an overview of the Canadian market, discuss the pathways for life sciences companies going public, address what investors are looking for, and how to value your company.
Both bring great expertise from which attendees will certainly benefit: Justin is the Head of Listings Business Development for the life sciences and diversified industries sectors with Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), and Douglas is an Analyst, Global Healthcare & Biotechnology with Byron Capital Markets. Don’t miss out!
Part of the MaRS Future of Medicine™ Series